$BTAIQ

$0.07 -$0.04 (37.11%) Close

$BTAIQ Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 31.3M shares outstanding

Who owns BTAIQ?

By type of holder

Institutions 19.7% Insiders 3.1% Everyone else 77.2%

Concentration Top 10 holders own 20.5%

Millennium Management LLC 6.8% · Oaktree Capital Management LP 4.4%

Institutional ownership

19.7%

+2.3 pts vs last qtr

Institutional holders

+6 vs last qtr

Net shares bought

+717.6K

by institutions in Q2 2026

New / sold out

9 / 3

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Oaktree Capital Management LP +1.1M
Vanguard Capital Management LLC +712.2K

Biggest sellers in Q2 2026

Armistice Capital, LLC SOLD OUT −1.9M
Man Group plc SOLD OUT −96.5K

Who is planning to sell?

Notices of proposed sale, last 12 months

$43.1K

4 notices from 4 people

Shares covered

39.7K

0.13% of the company

Arranged in advance

100%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Mehta Vimal Officer 10b5-1 $21.1K
Yocca Frank Officer 10b5-1 $7.43K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+570.4%

+158.92% a year

Each share's claim on the business

−85.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $27.5M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years27% 3–5 years0% 1–3 years28% Under 1 year45%

Quarterly turnover

44.9%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting BTAIQ on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MM Millennium Management LLC	2.1M	6.76%	+178.0K (+9.2%)	Q3 '25	0.0%
Shares held by quarter Peak holding2.1M (Q2'26) Change over 8 quarters+2.0M Share of the company6.760% Millennium Management LLC's full portfolio →
AC Armistice Capital, LLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding4.3M (Q4'24) Change over 8 quarters0 Armistice Capital, LLC's full portfolio →

Millennium Management LLC

2.1M

% of company

6.76%

Change vs last qtr

+178.0K (+9.2%)

Held since

Q3 '25

Armistice Capital, LLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

26 more super investors behind a free account

See every manager holding BioXcel Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting BTAIQ on Form N-PORT; together they hold 4.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$958K	679.6K	2.17%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$292K	207.3K	0.66%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$958K

% of company

2.17%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$292K

% of company

0.66%

% of the fund

0.00%

As of

June 30, 2026

10 more funds behind a free account

See every fund holding BioXcel Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
MV Mehta Vimal Insider	877.4K	2.80%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company2.800% Mehta Vimal's insider activity →
RJ Rodriguez Javier Insider	26.8K	0.09%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.090% Rodriguez Javier's insider activity →

Mehta Vimal

Insider

877.4K

% of company

2.80%

Change vs last qtr

—

Held since

—

Rodriguez Javier

Insider

26.8K

% of company

0.09%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of BioXcel Therapeutics Inc.

Comments